MRAI Quote, Financials, Valuation and Earnings

Cryo-Cell International, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 9.58%. Marpai, Inc.'s return on equity of -- beat Cryo-Cell International, Inc.'s return on equity of --.

Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Cryo-Cell International, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 140.11%. Given that Cryo-Cell International, Inc. has higher upside potential than Marpai, Inc., analysts believe Cryo-Cell International, Inc. is more attractive than Marpai, Inc..

Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cryo-Cell International, Inc. has a beta of 0.689, suggesting its less volatile than the S&P 500 by 31.12%.

Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International, Inc. offers a yield of 18.36% to investors and pays a quarterly dividend of $0.15 per share. Marpai, Inc. pays -- of its earnings as a dividend. Cryo-Cell International, Inc. pays out 510.2% of its earnings as a dividend.

Marpai, Inc. quarterly revenues are $4M, which are smaller than Cryo-Cell International, Inc. quarterly revenues of $7.8M. Marpai, Inc.'s net income of -$3.5M is lower than Cryo-Cell International, Inc.'s net income of $749.4K. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Cryo-Cell International, Inc.'s PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.53x versus 0.91x for Cryo-Cell International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Ensign Group, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 6.47%. Marpai, Inc.'s return on equity of -- beat The Ensign Group, Inc.'s return on equity of 16.99%.

Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand The Ensign Group, Inc. has an analysts' consensus of $207.20 which suggests that it could grow by 15.34%. Given that The Ensign Group, Inc. has higher upside potential than Marpai, Inc., analysts believe The Ensign Group, Inc. is more attractive than Marpai, Inc..

Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Ensign Group, Inc. has a beta of 0.861, suggesting its less volatile than the S&P 500 by 13.903%.

Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Ensign Group, Inc. offers a yield of 0.14% to investors and pays a quarterly dividend of $0.07 per share. Marpai, Inc. pays -- of its earnings as a dividend. The Ensign Group, Inc. pays out 4.74% of its earnings as a dividend. The Ensign Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Marpai, Inc. quarterly revenues are $4M, which are smaller than The Ensign Group, Inc. quarterly revenues of $1.3B. Marpai, Inc.'s net income of -$3.5M is lower than The Ensign Group, Inc.'s net income of $83.9M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while The Ensign Group, Inc.'s PE ratio is 31.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.53x versus 2.17x for The Ensign Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National HealthCare Corp. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 10.77%. Marpai, Inc.'s return on equity of -- beat National HealthCare Corp.'s return on equity of 10.22%.

Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand National HealthCare Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Marpai, Inc. has higher upside potential than National HealthCare Corp., analysts believe Marpai, Inc. is more attractive than National HealthCare Corp..

Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National HealthCare Corp. has a beta of 0.645, suggesting its less volatile than the S&P 500 by 35.519%.

Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National HealthCare Corp. offers a yield of 1.88% to investors and pays a quarterly dividend of $0.64 per share. Marpai, Inc. pays -- of its earnings as a dividend. National HealthCare Corp. pays out 37.04% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Marpai, Inc. quarterly revenues are $4M, which are smaller than National HealthCare Corp. quarterly revenues of $380.8M. Marpai, Inc.'s net income of -$3.5M is lower than National HealthCare Corp.'s net income of $41M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while National HealthCare Corp.'s PE ratio is 20.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.53x versus 1.41x for National HealthCare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Talkspace, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 5.48%. Marpai, Inc.'s return on equity of -- beat Talkspace, Inc.'s return on equity of 3.72%.

Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Talkspace, Inc. has an analysts' consensus of $4.86 which suggests that it could grow by 23.91%. Given that Talkspace, Inc. has higher upside potential than Marpai, Inc., analysts believe Talkspace, Inc. is more attractive than Marpai, Inc..

Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Talkspace, Inc. has a beta of 1.183, suggesting its more volatile than the S&P 500 by 18.296%.

Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Talkspace, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Marpai, Inc. pays -- of its earnings as a dividend. Talkspace, Inc. pays out -- of its earnings as a dividend.

Marpai, Inc. quarterly revenues are $4M, which are smaller than Talkspace, Inc. quarterly revenues of $59.4M. Marpai, Inc.'s net income of -$3.5M is lower than Talkspace, Inc.'s net income of $3.3M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Talkspace, Inc.'s PE ratio is 160.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.53x versus 3.16x for Talkspace, Inc.. Usually stocks with elevated PS ratios are considered overvalued.